NCT03720522 The Bern Heart and Brain Interaction Study - Interaction Between Brain and Heart in Acute Ischemic Stroke
| NCT ID | NCT03720522 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Acute Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2018-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2018-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute ischemic stroke is caused by blockage of blood vessels in the brain. Blood vessels can be obstructed by several different mechanisms and identification of this cause is essential to minimize the risk of recurrence.
Eligibility Criteria
Inclusion Criteria: * Informed consent as documented by signature. * Age: ≥ 18 and \< 86 years. * Acute ischemic stroke with symptom onset within 12 hours before admission to hospital. * Diagnosis of acute ischemic stroke with MRI with diffusion restriction as seen on diffusion weighted imaging. Exclusion Criteria: * Pregnancy. A negative pregnancy test upon admission is required for all women with child-bearing potential. * Standard contraindication for performing MRI. * Severe renal failure (GFR \<40).
Contact & Investigator
Simon Jung, PD Dr. med.
STUDY DIRECTOR
Dep. of Neurology, Inselspital Bern
Frequently Asked Questions
Who can join the NCT03720522 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 86 Years, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03720522 currently recruiting?
Yes, NCT03720522 is actively recruiting participants. Contact the research team at simon.jung@insel.ch for enrollment information.
Where is the NCT03720522 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT03720522 clinical trial?
NCT03720522 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Simon Jung, PD Dr. med. at Dep. of Neurology, Inselspital Bern. The trial plans to enroll 220 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.